Twitter to block users tweeting misinformation about Covid-19 vaccine

Twitter has announced to label Tweets that may contain misleading information around Covid vaccinations and will permanently suspend repeated offenders.

Twitter
IANS New Delhi
2 min read Last Updated : Mar 02 2021 | 12:30 PM IST

Don't want to miss the best from Business Standard?

Twitter has announced to label Tweets that may contain misleading information around Covid vaccinations and will permanently suspend repeated offenders.

The micro-blogging platform has introduced a strike system against such misleading tweets and five or more strikes will result in permanent suspension of the account.

"We believe the strike system will help to educate the public on our policies and further reduce the spread of potentially harmful and misleading information on Twitter, particularly for repeated moderate and high-severity violations of our rules," the company said in a statement late on Monday.

Since introducing the Covid-19 guidance, Twitter said it has removed more than 8,400 Tweets and challenged 11.5 million accounts worldwide.

While one strike will cause no account-level action, two strikes will lead to a 12-hour account lock; three strikes in another 12-hour account lock; four strikes in a 7-day account lock and five or more strikes means permanent suspension of the account.

Labels will first be applied by Twitter team members when they determine content violates the platform's policy.

"Our goal is to eventually use both automated and human review to address content that violates our Covid-19 vaccine misinformation rules," Twitter said.

Twitter will begin with English-language content first and use this same process as it works to expand to other languages and cultural contexts over time.

Labels will appear in the user's set display language and may link to curated content and official public health information or the Twitter Rules.

--IANS

na/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusLockdownCoronavirus VaccineCoronavirus Tests

First Published: Mar 02 2021 | 12:22 PM IST

Next Story